α-N-acetylgalactosaminidase in Methamphetamine Psychosis

Clinical trial NCT07434401 · COMPLETED

Trial details

NCT number: NCT07434401
Sponsor: Elazığ Mental Health and Diseases Hospital
Status: COMPLETED
Study type: OBSERVATIONAL

Methamphetamine Use Disorder Methamphetamine-induced Psychosis

Start date: 2025-05-01
Primary completion: 2025-08-31
Enrollment: 93

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.